Skip to main content
Industry News
2 AZ cancer drugs granted orphan status from FDA

Two cancer drugs by AstraZeneca, lung cancer treatment Imfinzi and tremelimumab, have both received the FDA's orphan drug designation. Both drugs are currently being tested as a combo therapy in patients with liver cancer in the company's late-stage study dubbed Himalaya.

Full Story: